RUSSO, FRANCESCO PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.949
EU - Europa 1.756
AS - Asia 1.412
AF - Africa 16
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 17.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.933
CN - Cina 836
IT - Italia 612
FI - Finlandia 295
SG - Singapore 273
SE - Svezia 245
DE - Germania 213
VN - Vietnam 190
GB - Regno Unito 164
UA - Ucraina 91
IN - India 55
IE - Irlanda 25
FR - Francia 24
NL - Olanda 18
RU - Federazione Russa 17
PK - Pakistan 15
ES - Italia 13
CA - Canada 12
TW - Taiwan 12
BR - Brasile 10
EG - Egitto 8
JP - Giappone 8
RO - Romania 8
BE - Belgio 7
HK - Hong Kong 5
IR - Iran 5
PL - Polonia 5
CZ - Repubblica Ceca 4
MX - Messico 4
AR - Argentina 3
CH - Svizzera 3
EU - Europa 3
PH - Filippine 3
SI - Slovenia 3
TR - Turchia 3
AU - Australia 2
DK - Danimarca 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SL - Sierra Leone 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
BG - Bulgaria 1
EC - Ecuador 1
HU - Ungheria 1
KW - Kuwait 1
LY - Libia 1
MA - Marocco 1
MK - Macedonia 1
RS - Serbia 1
Totale 17.155
Salva come PNG Salva come JPEG
Città #
Fairfield 2.523
Woodbridge 1.517
Houston 1.157
Chandler 1.083
Ashburn 1.052
Ann Arbor 1.041
Seattle 866
Cambridge 855
Wilmington 764
Jacksonville 364
San Diego 316
Princeton 291
Beijing 240
Des Moines 217
Medford 207
Padova 193
Dong Ket 190
Helsinki 156
Singapore 153
Roxbury 130
Nanjing 120
Boardman 89
Guangzhou 61
Shenyang 57
New York 51
London 42
Falls Church 40
Milan 39
Hebei 33
Jinan 31
Redwood City 26
Dublin 24
Nanchang 23
Ogden 22
Jiaxing 21
Kharkiv 19
Pune 19
Rome 19
Tianjin 19
Chicago 18
Zhengzhou 18
Changsha 17
Los Angeles 17
Washington 17
Hefei 16
Phoenix 16
Saint Petersburg 16
Vicenza 16
Borås 15
Shanghai 15
Kunming 14
Kilburn 13
Lappeenranta 13
Munich 13
Ningbo 13
Bologna 12
Paris 12
Dearborn 11
Taipei 11
Taizhou 11
Fuzhou 9
Hangzhou 9
Norwalk 9
Sahiwal 9
Trieste 9
Detroit 8
Pomezia 8
Amsterdam 7
Chiswick 7
Selvazzano Dentro 7
São Paulo 7
Arezzo 6
Dolo 6
Esslingen am Neckar 6
Haikou 6
Hounslow 6
Las Vegas 6
Prescot 6
Rockville 6
Southwark 6
Teramo 6
Venice 6
Verona 6
Hirakata 5
Islington 5
Livorno 5
New Bedfont 5
Treviso 5
Gavirate 4
Hong Kong 4
Indiana 4
Lanzhou 4
Naples 4
Nürnberg 4
Taiyuan 4
Tappahannock 4
Auburn Hills 3
Boston 3
Brno 3
Brussels 3
Totale 14.604
Salva come PNG Salva come JPEG
Nome #
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. 151
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 142
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 140
Heparanase and macrophage interplay in the onset of liver fibrosis 136
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 136
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 134
Understanding of and attitudes to xenotransplantation: a survey among Italian university students 131
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 129
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 128
The survival benefit of liver transplantation in hepatocellular carcinoma patients 127
Inflammatory bowel disease therapies adversely affect fertility in men- A systematic review and meta-analysis 126
Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro 125
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering 125
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 123
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 123
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 120
Use of ustekinumab in five psoriatic patients with hepatitis B virus infection 120
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 120
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 119
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 118
Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood. 117
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 117
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. 117
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 117
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 114
Experimental hepatology applied to stem cells 113
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation 112
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 110
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 110
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins 109
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 108
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 108
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 106
Markers of acute rejection and graft acceptance in liver transplantation. 106
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 106
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 106
Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure ? 105
AISF position paper on HCV in immunocompromised patients 105
Hepatitis C virus infection in end stage renal disease and kidney transplantation 104
Erratum to "A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list" [J Hepatol 2013;60:290-297]. 103
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 103
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis 102
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 101
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 101
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 100
Management of bacterial infection in the liver transplant candidate 100
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 100
HepaDisk – A new quality of life questionnaire for HCV patients 100
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 100
Compliance to medical regimen in patients before and after liver transplantation: are there any predictive factors? 98
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 98
The bone marrow functionally contributes to liver fibrosis 97
ESTIMATION OF THE HARM TO THE WAITING LIST AS CRUCIAL FACTOR IN THE SELECTION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION 97
Risk Factors in Liver Retransplantation: A Single-Center Experience RID D-7140-2011 97
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma 97
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort 96
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 94
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 94
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 94
Stem and progenitor cells in liver regeneration and repair 94
Young GI angle: A young point of view on translational medicine 94
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 93
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 92
Recent advances in understanding and managing liver transplantation 91
Adherence in Liver Transplant Recipients 91
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival 91
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 91
Galectin-3 regulates myofibroblast activation and hepatic fibrosis. 91
Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. 90
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 90
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) 89
Hepatic stem cells: from inside and outside the liver? 89
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 89
Histological features of donor grafts for orthotopic liver transplantation 88
Algorithm for prioritization of patients on the waiting list for liver transplantation. 88
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. 88
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 88
Immune response and gender disparity influence liver regeneration after acute hepatic injury 87
Prevalence of celiac disease in adult patients with refractory functional dyspepsia: Value of routine duodenal biopsy 86
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 86
Skin cancer and other cutaneous disorders in liver transplant recipients. 85
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 85
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 85
Bone marrow cells in the liver: diverse cells, diverse effects 84
Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review 84
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 84
Timing for treatment of HCV recurrence after liver transplantation: the earlier the better. 84
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 84
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 84
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 83
GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications 82
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 82
Is liver damage due to HCV recurrence after transplantation associated with histological features of donor graft ?. 81
Liver transplantation for HBV-related cirrhosis in Europe: a ELTR study on evolution and outcomes 81
Umbilical cord mesenchymal stem cells modulate dextran sulphate sodium induced acute colitis in immunodeficient mice. 81
Therapeutic application of stem cells in gastroenterology: an up-date 81
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 81
Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury 80
Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis 80
The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders 79
Totale 10.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.556
article - articoli 66.526
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 141
Totale 138.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.619 396 143 87 398 405 254 354 407 408 341 261 165
2020/20212.821 140 160 150 251 132 118 163 214 335 308 366 484
2021/20223.548 155 422 376 170 149 336 325 285 184 132 349 665
2022/20232.452 498 226 72 242 392 347 61 145 256 19 164 30
2023/20241.637 80 206 178 132 134 206 156 70 78 58 167 172
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 17.476